On the public citation graph

Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease

0 signed · 107 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2015.15629openalex-snapshot

Statins for Prevention of Cardiovascular Disease in Adults

inferredcites →https://doi.org/10.1001/jama.2016.14930openalex-snapshot

Colorectal Cancer Screening Recommendations—Reply

inferredcites →https://doi.org/10.1001/jama.2016.15085openalex-snapshot

Statins for Primary Prevention

inferredcites →https://doi.org/10.1001/jama.2016.15094openalex-snapshot

Evolving Approaches for Statins in Primary Prevention

inferredcites →https://doi.org/10.1001/jama.2016.15450openalex-snapshot

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults

inferredcites →https://doi.org/10.1016/j.atherosclerosis.2016.08.018openalex-snapshot

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

inferredcites →https://doi.org/10.1016/j.cjca.2016.07.510openalex-snapshot

2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

inferredcites →https://doi.org/10.1016/j.jclinepi.2010.03.016openalex-snapshot

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

inferredcites →https://doi.org/10.1016/j.jclinepi.2016.02.018openalex-snapshot

Evidence selection for a prescription drug's benefit-harm assessment: challenges and recommendations

inferredcites →https://doi.org/10.1016/j.mcna.2011.11.003openalex-snapshot

Age As a Risk Factor

inferredcites →https://doi.org/10.1016/s0140-6736(06)69472-5openalex-snapshot

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

inferredcites →https://doi.org/10.1016/s0140-6736(12)61680-8openalex-snapshot

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010

inferredcites →https://doi.org/10.1016/s1470-2045(16)00152-2openalex-snapshot

Under-reporting of harm in clinical trials

inferredcites →https://doi.org/10.1056/nejmoa1600176openalex-snapshot

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

inferredcites →https://doi.org/10.1093/eurheartj/ehw272openalex-snapshot

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

inferredcites →https://doi.org/10.1093/ije/dyi312openalex-snapshot

Bayesian perspectives for epidemiological research: I. Foundations and basic methods

inferredcites →https://doi.org/10.1093/jnci/91.21.1829openalex-snapshot

Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer

inferredcites →https://doi.org/10.1093/qjmed/hct041openalex-snapshot

Comparative effects of statins on major cerebrovascular events: a multiple-treatments meta-analysis of placebo-controlled and active-comparator trials

inferredcites →https://doi.org/10.1111/bcp.2008.67.issue-1openalex-snapshot

inferredcites →https://doi.org/10.1111/bcp.2013.75.issue-4openalex-snapshot

inferredcites →https://doi.org/10.1111/j.1365-2125.2008.03308.xopenalex-snapshot

Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials

inferredcites →https://doi.org/10.1111/j.1365-2125.2012.04403.xopenalex-snapshot

Statins and risk of treated incident diabetes in a primary care population

inferredcites →https://doi.org/10.1136/bmj.c2197openalex-snapshot

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

inferredcites →https://doi.org/10.1136/bmj.i4992openalex-snapshot

Statins: we need an independent review

inferredcites →https://doi.org/10.1136/bmj.i6334openalex-snapshot

Statins for primary prevention of cardiovascular disease

inferredcites →https://doi.org/10.1161/circoutcomes.111.000071openalex-snapshot

Comparative Tolerability and Harms of Individual Statins

inferredcites →https://doi.org/10.1186/1471-2288-12-173openalex-snapshot

A framework for organizing and selecting quantitative approaches for benefit-harm assessment

inferredcites →https://doi.org/10.1186/1741-7015-11-7openalex-snapshot

Support of personalized medicine through risk-stratified treatment recommendations - an environmental scan of clinical practice guidelines

inferredcites →https://doi.org/10.1186/s12872-018-0838-9openalex-snapshot

Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts

inferredcites →https://doi.org/10.1186/s12916-015-0430-4openalex-snapshot

Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles

inferredcites →https://doi.org/10.1186/s12916-015-0493-2openalex-snapshot

Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer

inferredcites →https://doi.org/10.1214/aos/1176345693openalex-snapshot

Piecewise Exponential Models for Survival Data with Covariates

inferredcites →https://doi.org/10.1345/aph.1c116openalex-snapshot

Therapeutic Controversies; Lack of Therapeutic Interchangeability of HMG-CoA Reductase Inhibitors

inferredcites →https://doi.org/10.1371/journal.pone.0127194openalex-snapshot

Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis

inferredcites →https://doi.org/10.7326/m17-0681openalex-snapshot

Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3863358openalex-extracted

A Benefit-Harm Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1001/jama.2023.9696openalex-snapshot

Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients

inferred← citeshttps://doi.org/10.1001/jamacardio.2019.2851openalex-snapshot

Cost-effectiveness of Low-density Lipoprotein Cholesterol Level–Guided Statin Treatment in Patients With Borderline Cardiovascular Risk

inferred← citeshttps://doi.org/10.1002/bimj.201900026openalex-snapshot

Extensions of the probabilistic ranking metrics of competing treatments in network meta‐analysis to reflect clinically important relative differences on many outcomes

inferred← citeshttps://doi.org/10.1002/jac5.1189openalex-snapshot

Addressing burnout in clinical pharmacy: What can we learn from other health care disciplines?

inferred← citeshttps://doi.org/10.1002/pds.5023openalex-snapshot

The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented

inferred← citeshttps://doi.org/10.1007/978-3-031-93933-4_3openalex-snapshot

The Government (Payer) Challenge

inferred← citeshttps://doi.org/10.1007/s00586-021-06954-6openalex-snapshot

Prognostic scores for survival as decisional support for surgery in spinal metastases: a performance assessment systematic review

inferred← citeshttps://doi.org/10.1007/s10198-022-01533-yopenalex-snapshot

The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease

inferred← citeshttps://doi.org/10.1007/s10238-020-00678-5openalex-snapshot

The association of transforming growth factor beta 1 gene polymorphisms with arthritis: a systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1016/j.ahj.2018.12.007openalex-snapshot

Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants

inferred← citeshttps://doi.org/10.1016/j.ajpc.2023.100468openalex-snapshot

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention

inferred← citeshttps://doi.org/10.1016/j.arbres.2021.09.018openalex-snapshot

The Hidden and Unchecked Judgement Calls When Using Exacerbation History for Managing COPD

inferred← citeshttps://doi.org/10.1016/j.cdnut.2022.100007openalex-snapshot

Serum Cholesterol Differences Between Statin Users Who Take Dietary Supplements and Those Who Do Not: NHANES 2013–2018

inferred← citeshttps://doi.org/10.1016/j.cpcardiol.2022.101529openalex-snapshot

Two Decades of Overuse and Underuse of Interventions for Primary and Secondary Prevention of Cardiovascular Diseases: A Systematic Review

inferred← citeshttps://doi.org/10.1016/j.eclinm.2024.102661openalex-snapshot

GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit–harm modelling study

inferred← citeshttps://doi.org/10.1016/j.ejogrb.2021.05.011openalex-snapshot

Predictive models of individual risk of elective caesarean section complications: a systematic review

inferred← citeshttps://doi.org/10.1016/j.euo.2022.04.007openalex-snapshot

Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment

inferred← citeshttps://doi.org/10.1016/j.jamda.2019.08.018openalex-snapshot

A Randomized Trial of Alerting to Hypocholesterolemia Results of the Low Indexes of Metabolism Intervention Trial-C (LIMIT-C)

inferred← citeshttps://doi.org/10.1016/j.jclinepi.2020.05.029openalex-snapshot

How personalized are benefit and harm results of randomized trials? A systematic review

inferred← citeshttps://doi.org/10.1016/j.jval.2019.11.007openalex-snapshot

Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit–Harm Assessments

inferred← citeshttps://doi.org/10.1016/j.msard.2020.102464openalex-snapshot

Benefit-harm balance of fingolimod in patients with MS: A modelling study based on FREEDOMS

inferred← citeshttps://doi.org/10.1016/j.scitotenv.2020.139076openalex-snapshot

SARS-CoV-2 in wastewater: State of the knowledge and research needs

inferred← citeshttps://doi.org/10.1016/s2589-7500(21)00130-8openalex-snapshot

Personalising add-on treatment with inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a benefit–harm modelling study

inferred← citeshttps://doi.org/10.1021/acsnano.3c02781openalex-snapshot

Chemotactic NO/H 2 S Nanomotors Realizing Cardiac Targeting of G-CSF against Myocardial Ischemia-Reperfusion Injury

inferred← citeshttps://doi.org/10.1056/nejm-jw.na48090openalex-snapshot

Another Model of Statins for Primary Prevention

inferred← citeshttps://doi.org/10.1080/09540261.2022.2113369openalex-snapshot

Statins in depression: a repurposed medical treatment can provide novel insights in mental health

inferred← citeshttps://doi.org/10.1093/ehjcvp/pvz033openalex-snapshot

Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology

inferred← citeshttps://doi.org/10.1093/jamia/ocab159openalex-snapshot

Learning decision thresholds for risk stratification models from aggregate clinician behavior

inferred← citeshttps://doi.org/10.1093/mr/roab082openalex-snapshot

Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohort

inferred← citeshttps://doi.org/10.1097/ec9.0000000000000056openalex-snapshot

Comparative effects of rosuvastatin and atorvastatin on the risk of new-onset diabetes mellitus in patients with acute coronary syndrome receiving percutaneous coronary intervention: a retrospective cohort study

inferred← citeshttps://doi.org/10.1097/sla.0000000000006877openalex-snapshot

Beyond P Values

inferred← citeshttps://doi.org/10.1111/jep.70558openalex-snapshot

Bringing Regulatory‐Style Benefit‐Risk Assessment to the Bedside: A Structured Evidence Synthesis Methodology for Shared Decision‐Making

inferred← citeshttps://doi.org/10.1136/bmj.k5110openalex-snapshot

Statins are overprescribed for primary prevention, study suggests

inferred← citeshttps://doi.org/10.1136/bmj.n1537openalex-snapshot

Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses

inferred← citeshttps://doi.org/10.1136/bmj.s464openalex-snapshot

New risk prediction model for managing COPD in primary care

inferred← citeshttps://doi.org/10.1136/bmjhci-2021-100460openalex-snapshot

Evaluating algorithmic fairness in the presence of clinical guidelines: the case of atherosclerotic cardiovascular disease risk estimation

inferred← citeshttps://doi.org/10.1136/bmjmed-2024-001132openalex-snapshot

Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study

inferred← citeshttps://doi.org/10.1136/bmjopen-2018-028438openalex-snapshot

Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment

inferred← citeshttps://doi.org/10.1136/thoraxjnl-2021-217962openalex-snapshot

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1155/2021/5568791openalex-snapshot

Use of Network Pharmacology to Investigate the Mechanism of the Compound Xuanju Capsule in the Treatment of Rheumatoid Arthritis

inferred← citeshttps://doi.org/10.1161/hypertensionaha.119.13749openalex-snapshot

Potential of Stratified Medicine for High Blood Pressure Management

inferred← citeshttps://doi.org/10.1177/2040622319877745openalex-snapshot

Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit–harm balance modeling study

inferred← citeshttps://doi.org/10.1177/20552173221117784openalex-snapshot

Fingolimod versus interferon beta 1-a: Benefit–harm assessment approach based on TRANSFORMS individual patient data

inferred← citeshttps://doi.org/10.1177/2333392818825414openalex-snapshot

Sex Differences in Statin Prescribing in Diabetic and Heart Disease Patients in FQHCs: A Comparison of the ATPIII and 2013 ACC/AHA Cholesterol Guidelines

inferred← citeshttps://doi.org/10.1183/13993003.00342-2021openalex-snapshot

Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk?

inferred← citeshttps://doi.org/10.1186/s12872-020-01697-6openalex-snapshot

Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study

inferred← citeshttps://doi.org/10.1186/s12872-024-04242-xopenalex-snapshot

Optimal risk thresholds for prescribing statins as primary prevention of cardiovascular disease in Iranian general population: a benefit-harm modelling study

inferred← citeshttps://doi.org/10.1186/s12911-020-01304-wopenalex-snapshot

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease

inferred← citeshttps://doi.org/10.1186/s12916-019-1425-3openalex-snapshot

Three myths about risk thresholds for prediction models

inferred← citeshttps://doi.org/10.1186/s12955-019-1250-6openalex-snapshot

Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling

inferred← citeshttps://doi.org/10.12997/jla.2022.11.3.308openalex-snapshot

Opposing View: A Blind Faith in Meta-Analyses in Academia Could Be a Threat to Public Health

inferred← citeshttps://doi.org/10.1371/journal.pmed.1003280openalex-snapshot

Projections of incident atherosclerotic cardiovascular disease and incident type 2 diabetes across evolving statin treatment guidelines and recommendations: A modelling study

inferred← citeshttps://doi.org/10.14309/ajg.0000000000001879openalex-snapshot

Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?

inferred← citeshttps://doi.org/10.18521/ktd.1112235openalex-snapshot

The Effect of Periodic Examination Time Interval and Frequency After “Percutaneous Coronary Intervention” on Experiencing Second "Acute Coronary Syndrome"

inferred← citeshttps://doi.org/10.21203/rs.3.rs-9824399/v1openalex-snapshot

Development and Validation of a Dual-Track Machine Learning System for Cardiovascular Risk Reclassification: A Gatekeeper-Guided Approach

inferred← citeshttps://doi.org/10.2215/cjn.0000000000000124openalex-snapshot

Incidence of Statin-Associated Adverse Events in Kidney Transplant Recipients

inferred← citeshttps://doi.org/10.22491/ats2023notastecnicas.rosuvastatinaopenalex-snapshot

Rosuvastatina comparada aos medicamentos disponíveis no SUS para prevenção primária e secundária de doenças cardiovasculares e tratamento de dislipidemia

inferred← citeshttps://doi.org/10.3389/fpubh.2021.694689openalex-snapshot

Meta-Decision in Healthcare

inferred← citeshttps://doi.org/10.3390/jcm9113748openalex-snapshot

Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers

inferred← citeshttps://doi.org/10.3390/nu13041206openalex-snapshot

A Combination of Lactoplantibacillus plantarum Strains CECT7527, CECT7528, and CECT7529 Plus Monacolin K Reduces Blood Cholesterol: Results from a Randomized, Double-Blind, Placebo-Controlled Study

inferred← citeshttps://doi.org/10.5772/intechopen.99344openalex-snapshot

Physiological and Cellular Functions of Vitamin K on Cardiovascular Function

inferred← citeshttps://doi.org/10.59556/japi.73.1048openalex-snapshot

Overdiagnosis and Overtreatment: Boon or Bane?

inferred← citeshttps://doi.org/10.6084/m9.figshare.12972022openalex-snapshot

Additional file 1 of Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study

inferred← citeshttps://doi.org/10.6084/m9.figshare.13191903openalex-snapshot

Additional file 1 of Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease

inferred← citeshttps://doi.org/10.7326/l19-0257openalex-snapshot